Pharmaceuticals

World Liver Disease Treatment Market - Opportunities and Forecast, 2014 - 2022

  • ALL22940
  • 150 Pages
  • July 2016
  • Pharmaceuticals

Liver disease comprises of wide range of complex conditions affecting the liver. Liver disease treatment market is assured to grow on account of unmet clinical needs and upcoming treatment modifications. Number of novel agents has shown improvements in clinical trials such as obeticholic acid, thiazolidinediones and vitamin E for treatment of nonalcoholic fatty liver diseases. Additionally, according to American Cancer Society liver cancer rates increases 2.7% every year propelling the growth of market.

Changing lifestyle such as increasing consumption of alcohol, unhealthy diets have increased the incidences of liver disease. Whereas, growing geriatric population has lead to significant addition in the world liver disease treatment market. There is huge market potential for this market as the occurrences of disorders have become common. Government and non government awareness programs would help the growth of liver disease treatment Industry. 

However, stringent government regulations (FDA, MHRA), high cost incurred in drug research and development pose a crucial challenge for liver disease treatment Industry. Side effect associated with medication is the growing concern expected for declining of market value. Patent expiry and growing health awareness in public would encourage the growth of the market. New research and development will provide immense opportunity for market players. For instance, Yaqrit Limited has developed a new product, Yaq-001 which will be introduced in 3 years for treatment of chronic liver diseases.

The liver disease treatment market is segmented into treatment type and geography. By treatment type the market is bifurcated into Chemotherapy drugs, targeted therapy, anti-viral drugs, immunoglobulins, corticosteroids, vaccines, anti-rejection drugs/immunosuppressant. By geography segmented into North America, Europe, APAC and LAMEA. North America is bifurcated into the U.S., Mexico and Canada whereas Europe have been further segmented into UK, Russia, Germany, Italy, France and rest of Europe. APAC comprises of China, India, Japan, South Korea, Taiwan and rest of Asia Pacific. LAMEA includes Latin America, Middle East and Africa. 

TOP WINNING STRATEGIES

Global Liver Diseases Therapeutics Market Growth and Industry Analysis

WHO estimated increase in liver disease due to rising alcohol drinking in Europe whereas; more than 1000 people die of liver cancer due to aflatoxin in western pacific region. The major companies covered under the scope of the study are Gilead Science Inc., Bayer AG, AstraZeneca, GlaxoSmithKline plc, Merck & Co. Inc, Sanofi, Pfizer Inc., F. Hoffmann-La Roche AG, Novartis AG, and Johnson &Johnson Private Limited among others

Changing lifestyle patterns such as increasing consumption of alcohol, unhealthy diets

Unhealthy diet, high stress levels and unorganized lifestyle patterns are the major driving forces of liver disease treatment market. Numbers of overweight and obesity in developed countries have quadrupled since 1980 thereby, escalating the risk of liver diseases. In addition, growing alcohol consumption has fueled rise in fatal liver disease. These drivers have increased incidences of liver diseases which would propel the growth of liver disease treatment market in future. 

Increasing incidences of liver diseases

Increasing incidences of obesity, metabolic syndrome, diabetes and cardiovascular disorders that lead to liver diseases are another major factor boosting the growth of liver disease treatment market. Additionally, increasing prevalence of liver disease due to side effects of other drugs such as acetaminophen and poor hygienic and sanitation conditions are expected to drive the market in the coming years. 

Growing geriatric population

Structural dysfunction or alteration due to aging mainly leads to liver diseases. According to the National Institute of Aging, geriatric population is likely to increase by 86% till 2050. The increasing rates of geriatric population have resulted in rise of the incidences of liver diseases, which further escalating the demand of liver disease treatment market.

Government and non government awareness program /Liver organizations

With increasing prevalence of liver diseases, increasing awareness has become a necessity. Government and not-for-profit organizations are playing a crucial role in the rising awareness about the liver diseases around the world. These organizations promote the awareness of the liver related diseases and support for research and development for the prevention, treatment and cure of liver diseases. 

Increasing R&D to develop innovative products

Several companies are investing in their R&D to develop innovative and advanced treatment for liver disease. Research and development of high efficient and less or no side effects pharmaceutical drugs would drive the market in the near future. 

Availability of generic and bio-similar drugs

Patent expiry in upcoming years of various block-buster liver disease treatment drugs have created new gateway for the entrance of generic market. Moreover, due to the low cost of generic drugs compared to the branded therapies, there is more preference towards generic drugs or bio similar drugs for the treatment of various diseases.

KEY BENEFITS FOR SHAREHOLDERS

  • The report provides information regarding key drivers, restraints and opportunities with detailed analysis 
  • The study provides an in-depth analysis of the fast food market with current and future trends to elucidate the imminent investment pockets in the liver disease treatment market
  • Current and future trends are outlined which will help new entrants and key players to gain a stronger foothold in the market
  • Quantitative analysis of the current market and estimations through 2014-2022 are provided to showcase the financial competency of the market
  • Porters Five Forces model of the industry illustrates the potency of the buyers & suppliers participating in the market 
  • Comprehensive analyses of all geographical regions are presented that determines predominant opportunities in these geographies
  • Key market players of liver disease treatment are analyzed to understand the competitive outline of the world liver disease treatment market

KEY MARKET SEGMENTS:

  • By Treatment Type:
    • Anti-Rejection Drugs/Immunosupressants
    • Chemotherapy Drugs
    • Targeted therapy
    • Vaccines
    • Anti-Viral Drugs
    • Immunoglobulins
    • Corticosteroids 
  • By Geography:
    • North America
      • U.S.
      • Mexico
      • Canada
    • Europe
      • UK
      • Russia 
      • Germany
      • Italy
      • France
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • LAMEA
      • Latin America 
      • Middle East
      • Africa 
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Hemoglobinopathies Market (Pipeline Therapeutics and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules, particularly defective globin chains. Hemoglobinopathies are inherited single-gene disorders of which sickle cell disease is the most common ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Human Insulin Market (Product Type, Brand and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

RNA-Based Therapeutics Asia-Pacific Market Research Report, 2014 - 2021

The RNA-based therapeutics involves broad range of the RNA-based technologies, which help the patients to diagnose or treat various chronic diseases. The RNA-based therapeutics play a crucial role in providing ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Oral Proteins and Peptides Market (Drugs, technology, geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast, 2013 - 2020

Oral Proteins and Peptides are the formulations that are orally administered by the patient. Usually, formulations containing proteins and peptides are administered via intravenous and subcutaneous route due to instability ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Biosimulation Market (Applications and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Biosimulation refers to simulation of biological processes by means of computer program. Biosimulation technology has wide application in drug discovery and development. It is a predictive tool and used in ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>